Correlation between Hepatitis B Viral Load and Liver Function Test among Hepatitis B Virus Patients in Khartoum State, Sudan
DOI:
https://doi.org/10.37375/sjms.v2i2.2539Keywords:
hepatitis B, viral load, inflammation, hepatologyAbstract
Hepatitis B virus (HBV) infection is a global public health problem. Sudan is classified among the countries with high hepatitis B virus seroprevalence . The purpose of this study was to study the correlation between the hepatitis B viral load and the liver function test in hepatitis BV patients Descriptive cross-sectional hospital based study conducted at the hepatology clinic Ibn Sinaa teaching hospital, covering all the patients who presented to the clinic from March-April 2018, primary data was collected from the patients and/or their care giver, a specifically designed questionnaire was used, and then the data was re-entered into a predesigned data collection form. A P value of 0.05 or less was considered statistically significant. The Data was analyzed using Social Package Statistical Analysis version (24). A total of 83 patients, 19 (22.9%) have viral load level less than 20 IU\ml, 33(39.8%) have viral ranging between (20-2000IU\ ML ), 13 (15.6%)have viral load between (2000-20,000IU\ML ) and 18(21.7%)have viral load more than 20,000IU\ML ) . The study showed a significant correlation between hepatitis B viral load and alanine aminotransferase level (ALT) with a P value of 0.027. The study showed a significant correlation between hepatitis B viral load and aspartate aminotransferase level (AST) with a P value of 0.009 .The study also showed there was a significant relation between hepatitis B viral load and serum albumin level with a P value of 0.007. Hepatitis B viral load was not affected by the age, gender or the duration of the disease. The liver function tests is recommended to be used as an indicator for the hepatitis B viral load and the degree of liver inflammation.
References
Biazar T, , Yousef Y, Mohammad R Hasanjani R, Ramazan R, Mahmoud Si, Hasan T, Mohammad Ri, and Masomeh B. (2015). Caspian J Intern Med. Autumn; 6(4): 209–212.
Horn J, Mikolajczyk R, Krause G, Ott J.(2015). Estimations of worldwide prevalence of chronic hepatitis B virus infection: A systematic review of data published between 1965 and 2013. Lancet;386:1546–1555.
Maini M, Gehring A. (2016). The role of innate immunity in the immunopathology and treatment of HBV infection. J Hepatol;64:S60–S70.
Mudawi H. (2008). ClinExpGastroenterol.;1:9-13. Epub Dec 11 PMID: 21677820.
Ott J, Stevens G, Groeger J, Wiersma S. (2012). Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAgseroprevalence and endemicity. Vaccine;30:2212–2219.
Seeger C, Mason W. (2015). Molecular biology of hepatitis B virus infection.Virology;479–480:672–686
Stanaway J, Flaxman A, Naghavi M, Fitzmaurice C, Vos T, Abubakar I et al. (2013).The global burden of viral hepatitis from 1990 to 2013: findings fromthe global burden disease study . Lancet ;388:1081–1088.
Tong S, Revill P. (2016). Overview of hepatitis B viral replication and genetic variability. J Hepatol;64:S4–S16.
Zhonghua G, Bing Z. (2015). Jan;23(1):40-5. doi: 10.3760/cma.j.issn.1007-3418.2015.01.010